Data Management

A high performing team of global data management experts.

Everyone on the MMS team has been so collaborative and responsive. It is rare to have such a seamless experience.
Biometrics Leader
Large Pharmaceutical Partner

Driven by quality, the experts at MMS approach every biometrics deliverable as a top priority, no matter the size or scope of the project. You and your team can expect in-depth, thoughtful conversations with team members, knowing that they are thought leaders, invited speakers, and change makers in industry groups across the globe.

Certified in multiple industry esteemed EDC platforms, allowing for flexible approach to database builds and efficiencies to tailor to Sponsor requirements as projects progress.

Data Management services at MMS are designed to streamline  the process of design, collection, reconciliation, and review of clinical research data. Our clinical data specialists manage all aspects of the data while you stay in complete control — with continuous access to data and total transparency to study progress.

Working with MMS brings:

  • An experienced, award-winning team to manage studies across a variety of industry leading EDC platforms, including accreditations to build in Rave, Zelta, and Medrio
  • Expertise to recommend and deploy cutting-edge “e” technologies, including eCOA (eClinRO and ePRO), eDiary, and eConsent 
  • A wide range of therapeutic area expertise
  • Proven processes to begin clinical studies faster, with accurate, clean results that exceed expectations
  • Near real-time access to clean clinical data, including added visibility via Datacise technology
  • A single point of contact, reducing communication burden and increasing historical knowledge

MMS Clinical Data Managers provide: 

  • Expert knowledge on EDC technology and surrounding processes
  • Clean, reproducible fit-for-analysis data, with cross functional support from the entire biometrics team
  • Lead Data Managers that rise to the challenge of aggressive study timelines
  • Knowledge transfer and industry-leading CRO retention rates increase efficiencies to propel study conduct to the finish line while ensuring data integrity

Suggested For You

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

regulatory intelligence

August 27th, 2024

Recent Guidance on Diversity Action Planning

regulatory intelligence

August 26th, 2024

Oncology Programs at the FDA

regulatory intelligence

August 26th, 2024

Three Key Take Reflections on the Recent Donanemab Approval

webinar

September 12th, 2024

No Stone Unturned: Optimizing the Use of Expedited Pathways and Oncology Center of Excellence Programs to Optimize Drug Development in Oncology

regulatory intelligence

August 9th, 2024

FDA Updates 2024 Language Access Plan

regulatory intelligence

August 3rd, 2024

EMA Launches New Pilot Program for Orphan Medical Devices

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

regulatory intelligence

July 26th, 2024

Key Decision Points for Recent Oncology Approvals

regulatory intelligence

July 24th, 2024

Comments Open for Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

news

July 17th, 2024

Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization